AMGN vs REGN
AMGN and REGN side by side — valuation & fundamentals (public data).
Key statistics
| Metric | AMGNAmgen Inc. | REGNREGENERON PHARMACEUTICALS, INC. |
|---|---|---|
| Market cap | $203.14B | — |
| P/E (TTM) | 23.3 | 19.1 |
| P/B | 17.38 | — |
| P/S | 5.5x | — |
| Dividend yield | 2.52% | — |
| Revenue | $38.09B(TTM) | $15.53B(TTM) |
| Revenue growth (YoY) | 10.0% | 1.0% |
| Net income | $8.74B(TTM) | $4.33B(TTM) |
| Earnings growth (YoY) | 88.5% | 2.1% |
| EPS, diluted | $16.10(TTM) | $40.41(TTM) |
| EBIT margin | 24.7% | 24.9% |
| ROE | 66.0% | 14.2% |
| ROIC | 15.1% | 9.4% |
| 1y total return | +40.3% | +35.0% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: AMGN vs REGN
| 지표 | AMGN | REGN |
|---|---|---|
| 최종 가치 | $33.5K | $21.4K |
| 총수익률 | +235.2% | +113.7% |
| CAGR | +12.4% | +7.6% |
| 변동성 | 25.0% | 32.1% |
| 샤프 | 0.43 | 0.26 |
| 소르티노 | 0.63 | 0.38 |
| 최대 낙폭 | -24.9% | -59.7% |
공통 거래일 2600일 기준, 2016-05-12 → 2026-09-15 · 무위험수익률 4.11% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)